The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Impact of Epithelial–Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
Open accessAbstract
Background: A better definition of biomarkers and biological processes related to local recurrence and disease progression is highly warranted for ductal breast carcinoma in situ (DCIS). Stromal–epithelial interactions are likely of major importance for the biological, clinical, and pathological distinctions between high- and low-risk DCIS cases. Methods: Stromal platelet derived growth factor receptor (PDGFR) was immunohistochemically assessed in two DCIS patient cohorts (n = 458 and n = 80). Cox proportional hazards models were used to calculate the hazard ratios of recurrence. The molecular mechanisms regulating stromal PDGFR expression were investigated in experimental in vitro co-culture systems of DCIS cells and fibroblasts and analyzed using immunoblot and quantitative real-time PCR. Knock-out of JAG1 in DCIS cells and NOTCH2 in fibroblasts was obtained through CRISPR/Cas9. Experimental data were validated by mammary fat pad injection of DCIS and DCIS-JAG1 knock-out cells (10 mice per group). All statistical tests were two-sided. Results: PDGFRα(low)/PDGFRβ(high) fibroblasts were associated with increased risk for recurrence in DCIS (univariate hazard ratio = 1.59, 95% confidence interval [CI] = 1.02 to 2.46; P = .04 Wald test; multivariable hazard ratio = 1.78, 95% CI = 1.07 to 2.97; P = .03). Tissue culture and mouse model studies indicated that this fibroblast phenotype is induced by DCIS cells in a cell contact-dependent manner. Epithelial Jagged1 and fibroblast Notch2 were identified through loss-of-function studies as key juxtacrine signaling components driving the formation of the poor prognosis-associated fibroblast phenotype. Conclusions: A PDGFRα(low)/PDGFRβ(high) fibroblast subset was identified as a marker for high-risk DCIS. The Jagged-1/Notch2/PDGFR stroma–epithelial pathway was described as a novel signaling mechanism regulating this poor prognosis-associated fibroblast subset. In general terms, the study highlights epithelial–stromal crosstalk in DCIS and contributes to ongoing efforts to define clinically relevant fibroblast subsets and their etiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Contact between cancer cells and fibroblasts can promote the CAF phenotype in breast cancer through Notch signalling55”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [55]
Citations
Cites
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085
Cox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569
GAGE: generally applicable gene set enrichment for pathway analysis
Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D., & Woolf, P. J. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-161 · Cited by 1,333
Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5
Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., & Quaranta, V. (1997) · Science · doi:10.1126/science.277.5323.225 · Cited by 1,221
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 975
Rosen, P. P. (1997) · Cited by 820
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Boelens, M. C., Wu, T. J., Nabet, B. Y., Xu, B., Qiu, Y., Yoon, T., Azzam, D. J., Victor, C. T.-S., Wiemann, B. Z., Ishwaran, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.051 · Cited by 819
Cited by
Sorted by citations
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863
Notch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,216
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.
Kieffer, Y., Hocine, H. R., Gentric, G., Pelon, F., Bernard, C., Bourachot, B., Lameiras, S., Albergante, L., Bonneau, C., Guyard, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1384 · Cited by 910
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 463
Pelon, F., Bourachot, B., Kieffer, Y., Magagna, I., Mermet‐Meillon, F., Bonnet, I., Costa, A., Givel, A.-M., Atieh, Y., Barbazán, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14134-w · Cited by 404
Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities
Hu, D., Li, Z., Zheng, B., Lin, X., Pan, Y., Gong, P., Zhuo, W., Hu, Y., Chen, C., Chen, L., et al. (2022) · 癌症：英文版 · doi:10.1002/cac2.12291 · Cited by 310
Targeting Notch in oncology: the path forward
Majumder, S., Crabtree, J. S., Golde, T. E., Minter, L. M., Osborne, B. A., & Miele, L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00091-3 · Cited by 279
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Mhaidly, R., & Mechta‐Grigoriou, F. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101417 · Cited by 267
Mhaidly, R., & Mechta‐Grigoriou, F. (2021) · Immunological Reviews · doi:10.1111/imr.12978 · Cited by 231
Liu, Y., Sinjab, A. F., Min, J., Han, G., Paradiso, F., Zhang, Y., Wang, R., Pei, G., Dai, Y., Liu, Y., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.004 · Cited by 268
Epithelial cells activate fibroblasts to promote esophageal cancer development
Chen, Y., Zhu, S., Liu, T., Zhang, S., Lu, J., Fan, W., Lin, L., Xiang, T., Yang, J., Zhao, X., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.03.001 · Cited by 207
Stromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression
Primac, I., Maquoi, E., Blacher, S., Heljäsvaara, R., Deun, J. V., Smeland, H. Y., Canale, A., Louis, T., Stuhr, L. E. B., Sounni, N. E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125890 · Cited by 155
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
The harsh microenvironment in early breast cancer selects for a Warburg phenotype
Damaghi, M., West, J., Robertson‐Tessi, M., Xu, L., Ferrall‐Fairbanks, M. C., Stewart, P. A., Persi, E., Fridley, B. L., Altrock, P. M., Gatenby, R. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011342118 · Cited by 146
Saha, T., & Lukong, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856974 · Cited by 148
Gu, X., Zhu, Y., Su, J., Wang, S., Su, X., Ding, X., Jiang, L., Fei, X., & Zhang, W. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103209 · Cited by 138
Wong, H. Y., Sheng, Q., Hesterberg, A. B., Croessmann, S., Rios, B. L., Giri, K. R., Jackson, J., Miranda, A. X., Watkins, E., Schaffer, K. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33780-1 · Cited by 131
Xiang, X., Niu, Y., Wang, Z.-H., Ye, L., Peng, W., & Zhou, Q. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.07.006 · Cited by 123
Jurj, A. M., Ionescu, C., Berindan‐Neagoe, I., & Braicu, C. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02484-1 · Cited by 113
Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
Peltier, A., Seban, R., Buvat, I., Bidard, F., & Mechta‐Grigoriou, F. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.008 · Cited by 96
Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment
Kim, I., Choi, S., Yoo, S., Lee, M., & Kim, I. (2022) · Cancers · doi:10.3390/cancers14143321 · Cited by 107
The oncogenic role of Jagged1/Notch signaling in cancer
Xiu, M., Liu, Y., & Kuang, B. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110416 · Cited by 93
Duan, M., Liu, H., Xu, S., Yang, Z., Zhang, F., Wang, G., Wang, Y., Zhao, S., & Jiang, X. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.06.017 · Cited by 88
Chen, P., Wei, W.-F., Wu, H.-Z., Fan, L., & Wang, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671595 · Cited by 80
Xue, B., Chuang, C.-H., Prosser, H. M., Fuziwara, C. S., Chan, C., Sahasrabudhe, N. S., Kühn, M., Wu, Y., Chen, J., Biton, A., et al. (2021) · Genes & Development · doi:10.1101/gad.347344.120 · Cited by 74
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
Bonneau, C., Eliès, A., Kieffer, Y., Bourachot, B., Ladoire, S., Pelon, F., Héquet, D., Guinebretière, J. M., Blanchet, C., Vincent‐Salomon, A., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01311-9 · Cited by 70
Mezheyeuski, A., Segersten, U., Leiss, L. W., Malmström, P., Hatina, J., Östman, A., & Strell, C. (2020) · Scientific Reports · doi:10.1038/s41598-019-55013-0 · Cited by 68
Self-citationCancer associated fibroblasts: role in breast cancer and potential as therapeutic targets
Lappano, R., Rigiracciolo, D. C., Belfiore, A., Maggiolini, M., & Francesco, E. M. D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1751819 · Cited by 71
Cancer-Associated Fibroblasts and T Cells: From Mechanisms to Outcomes
Baker, A. T., Abuwarwar, M. H., Poly, L., Wilkins, S., & Fletcher, A. L. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001203 · Cited by 72
Micke, P., Strell, C., Mattsson, J. S. M., Martín-Bernabé, A., Brunnström, H., Huvila, J. K., Sund, M., Wärnberg, F., Pontén, F., Glimelius, B. L. G., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103269 · Cited by 65
Self-citationNedaeinia, R., Najafgholian, S., Salehi, R., Goli, M., Ranjbar, M., Nickho, H., Javanmard, S. H., Ferns, G. A., & Manian, M. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02146-5 · Cited by 69
Yu, S., Wang, S., Wang, X., & Xu, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03518-8 · Cited by 70
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 62
Roles of Notch Signaling in the Tumor Microenvironment
D’Assoro, A. B., Leon-Ferre, R. A., Braune, E.-B., & Lendahl, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116241 · Cited by 63
Self-citationVenning, F. A., Zornhagen, K. W., Wullkopf, L., Sjölund, J., Rodriguez-Cupello, C., Kjellman, P., Morsing, M., Hajkarim, M. C., Won, K., Erler, J. T., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01944-4 · Cited by 61
The role of Hedgehog and Notch signaling pathway in cancer
Xia, R., Xu, M., Yang, J., & Ma, X. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00099-8 · Cited by 62
Notch signaling in cancer: Complexity and challenges on the path to clinical translation
Ferreira, A. P. A., & Aster, J. C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.008 · Cited by 56
Owen, J. S., Clayton, A., & Pearson, H. B. (2022) · Biomolecules · doi:10.3390/biom13010067 · Cited by 60
Gao, D., Fang, L., Liu, C., Yang, M., Yu, X., Wang, L., Zhang, W., Sun, C., & Zhuang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115622 · Cited by 52
Qadir, J., Wen, S.-Y., Yuan, H., & Yang, B. B. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.12.005 · Cited by 52
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Gentric, G., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13030399 · Cited by 52
Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues
Elwakeel, E., & Weigert, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111636 · Cited by 49
Zou, R., Jiang, Q., Jin, T., Chen, M., Yao, L., & Ding, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956224 · Cited by 44
A review concerning the breast cancer-related tumour microenvironment
Rodríguez-Bejarano, O. H., Parra-López, C., & Patarroyo, M. A. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104389 · Cited by 47
Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
Mancini, S. J. C., Balabanian, K., Corre, I., Gavard, J., Lazennec, G., Bousse‐Kerdilès, M. L., Louache, F., Maguer‐Satta, V., Mazure, N. M., Mechta‐Grigoriou, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766275 · Cited by 43
The role of cancer-associated fibroblasts in breast cancer metastasis
Li, Y., Wang, C., Huang, T. H., Yu, X., & Tian, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1194835 · Cited by 39
Magagna, I., Gourdin, N., Kieffer, Y., Licaj, M., Mhaidly, R., André, P., Morel, A., Vincent‐Salomon, A., Paturel, C., & Mechta‐Grigoriou, F. (2021) · Cancers · doi:10.3390/cancers13235878 · Cited by 40
Tan, K., & Naylor, M. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.876451 · Cited by 39
Meng, Q., Luo, X., Chen, J., Wang, D., Chen, E., Zhang, W., Zhang, G., Zhou, W., Xu, J., & Song, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188443 · Cited by 38
Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives
Toledo, B., Picon‐Ruiz, M., Marchal, J. A., & Perán, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415576 · Cited by 41
Huang, J., Tsang, W. Y., Li, Z., & Guan, X. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.07.001 · Cited by 42
Zhang, X., Zhu, R., Yu, D., Wang, J., Yan, Y., & Xu, K. (2023) · Cell Proliferation · doi:10.1111/cpr.13592 · Cited by 35
Elwakeel, E., Brüggemann, M., Wagih, J., Lityagina, O., Elewa, M. A. F., Han, Y., Frömel, T., Popp, R., Nicolas, A. M., Schreiber, Y., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2116 · Cited by 32
CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
Tănase, C., Gheorghișan-Gălățeanu, A.-A., Popescu, I. D., Mihai, S., Codrici, E., Albulescu, R., & Hinescu, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165656 · Cited by 32
Everybody needs good neighbours: the progressive DCIS microenvironment
Gibson, S. V., Roozitalab, R., Allen, M. D., Jones, J. L., Carter, E. P., & Grose, R. P. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.01.002 · Cited by 31
Functional and clinical roles of stromal PDGF receptors in tumor biology
Strell, C., Rodríguez‐Tomàs, E., & Östman, A. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10194-7 · Cited by 31
Self-citationTumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
Yan, D., Ju, X., Luo, B., Guan, F., He, H., Yan, H., & Yuan, J. (2022) · BMC Cancer · doi:10.1186/s12885-022-10183-5 · Cited by 30
Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC
Kilvaer, T. K., Rakaee, M., Hellevik, T., Vik, J., Petris, L. D., Dønnem, T., Strell, C., Östman, A., Busund, L., & Martínez-Zubiaurre, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-46510-3 · Cited by 30
Self-citationMolecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer
Plundrich, D., Chikhladze, S., Fichtner‐Feigl, S., Feuerstein, R., & Briquez, P. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052782 · Cited by 31
Microfluidic-based human prostate-cancer-on-chip
Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T. A., Miranti, C. K., & Zohar, Y. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1302223 · Cited by 26
Unlocking antitumor immunity with adenosine receptor blockers
Remley, V. A., Linden, J. M., Bauer, T. W., & Dimastromatteo, J. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.63 · Cited by 27
Trnkova, L., Buociková, V., Mego, M., Čumová, A., Buríková, M., Boháč, M., Miklikova, S., Cihova, M., & Smolková, B. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116559 · Cited by 29
Musa, M., & Ali, A. (2020) · Future Oncology · doi:10.2217/fon-2020-0384 · Cited by 26
Schiza, A., Thurfjell, V., Tullberg, A. S., Olofsson, H., Lindberg, A., Holmberg, E. C., Bremer, T. M., Micke, P., Karlsson, P., Wärnberg, F., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.01.016 · Cited by 23
Self-citationStrell, C., Tullberg, A. S., Edelmann, R. J., Akslen, L. A., Malmström, P., Fernö, M., Holmberg, E. C., Östman, A., & Karlsson, P. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06136-4 · Cited by 22
Self-citationExtracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment
Samuels, M., Cilibrasi, C., Papanastasopoulos, P., & Giamas, G. (2022) · Biomolecules · doi:10.3390/biom12010132 · Cited by 23
Cancer-associated fibroblasts in carcinogenesis
Zhou, S., Zhao, Z., Wang, Z., Xu, H., Li, Y., Xu, K., Li, W., & Yang, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06071-8 · Cited by 25
Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma
Arebro, J., Lee, C.-M., Bennewith, K. L., & Garnis, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021300 · Cited by 25
Fibroblasts in cancer: Defining target structures for therapeutic intervention
Boesch, M., Baty, F., Rumpold, H. F., Sopper, S., Wolf, D. G. F., & Brutsche, M. H. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.06.003 · Cited by 20
Phenotype transition of fibroblasts incorporated into patient‐derived oral carcinoma organoids
Chen, X., Li, R., Zhao, H., Wang, X., Shao, Z., & Shang, Z. (2021) · Oral Diseases · doi:10.1111/odi.14071 · Cited by 19
Ephrin B Activate Src Family Kinases in Fibroblasts Inducing Stromal Remodeling in Prostate Cancer
Kakarla, M., ChallaSivaKanaka, S., Dufficy, M. F., Gil, V., Filipovich, Y., Vickman, R. E., Crawford, S. E., Hayward, S. W., & Franco, O. E. (2022) · Cancers · doi:10.3390/cancers14092336 · Cited by 19
Ahn, S., Kwon, A., Huh, Y. H., Rhee, S., & Song, W. K. (2022) · Oncogenesis · doi:10.1038/s41389-022-00422-6 · Cited by 20
Xue, C., Gao, Y., Sun, Z., Li, X., Zhang, M., Yang, Y., Han, Q., Bai, C., & Zhao, R. C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837781 · Cited by 18
Burley, A., Rullan, A., & Wilkins, A. C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000888 · Cited by 19
Single cell imaging-based chromatin biomarkers for tumor progression
Venkatachalapathy, S., Jokhun, D. S., Andhari, M. D., & Shivashankar, G. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-02441-6 · Cited by 17
Role of autophagy in cancer-associated fibroblast activation, signaling and metabolic reprograming
Sari, D., Gözüaçık, D., & Akkoç, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1274682 · Cited by 18
Zhang, Z., & Wu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1641518 · Cited by 18
Magoulopoulou, A., Qian, X., Setiabudiawan, T. P., Salas, S. M., Yokota, C., Rottenberg, M. E., Nilsson, M. F., & Carow, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876321 · Cited by 15
Self-citationHulahan, T. S., & Angel, P. M. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03236-z · Cited by 17
Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma
Zhang, X., Bi, X., Liu, P., Liu, Z.-L., Nie, M., Yang, H., Lei, D., Xia, Y., Jiang, W., & Zeng, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01360 · Cited by 16
Strell, C., Folkvaljon, D., Holmberg, E. C., Schiza, A., Thurfjell, V., Karlsson, P., Bergh, J. C. S., Bremer, T. M., Akslen, L. A., Wärnberg, F., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4300 · Cited by 16
Self-citationIdentifying recurrences and metastasis after ductal carcinoma in situ ( DCIS ) of the breast
Udayasiri, R. I., Luo, T., Gorringe, K. L., & Fox, S. B. (2022) · Histopathology · doi:10.1111/his.14804 · Cited by 16
Wu, D., Wang, S., Oliveira, D. V., Gaudio, F. D., Vanlandewijck, M., Lebouvier, T., Betsholtz, C., Zhao, J., Jin, S., Lendahl, U., et al. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.046300 · Cited by 16
Self-citationYamaguchi, H., & Miyazaki, M. (2024) · Cancers · doi:10.3390/cancers16091636 · Cited by 15
Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response
Xiao, Y., Wang, Z., Gu, M., Wei, P., Wang, X., & Li, W. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01375-3 · Cited by 15
Lian, W., Xiang, P., Ye, C., & Xiong, J. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673282799231211113347 · Cited by 14
A Simple Framework for Agent-Based Modeling with Extracellular Matrix
Metzcar, J., Duggan, B. S., Fischer, B., Murphy, M., Heiland, R. W., & Macklin, P. (2025) · Bulletin of Mathematical Biology · doi:10.1007/s11538-024-01408-8 · Cited by 14
Metastasis and cancer associated fibroblasts: taking it up a NOTCH
Ghosh, A., & Mitra, A. K. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1277076 · Cited by 11
Fouillet, J., Torchio, J., Rubira, L., & Fersing, C. (2024) · Biology · doi:10.3390/biology13120967 · Cited by 12
Noh, K. H., Jeong, A. J., Lee, H., Lee, S. H., Yi, E. S., Chang, P., Kwak, C. H., & Ye, S. K. (2020) · Cancers · doi:10.3390/cancers12051083 · Cited by 12
Cui, M., Dong, H., Duan, W., Wang, X., Liu, Y., Shi, L., & Zhang, B. (2024) · PeerJ · doi:10.7717/peerj.16958 · Cited by 11
A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation
Mega, A., Mebrahtu, A., Aniander, G., Ryer, E., Sköld, A. E., Sandegren, A., Rydin, E. B., Rockberg, J., Östman, A., & Frejd, F. Y. (2023) · mAbs · doi:10.1080/19420862.2023.2223750 · Cited by 11
Self-citationChoi, J., Kwak, Y., Park, M., Jo, J. Y., Kang, J. H., Kook, M., Kim, H., Kim, G., Kong, S., Park, D. J., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01447-8 · Cited by 10
Cell-cell interactions that drive tumorigenesis in Drosophila
Enomoto, M., & Igaki, T. (2022) · Fly · doi:10.1080/19336934.2022.2148828 · Cited by 10
Devarasou, S., Kang, M., Kwon, T. Y., Cho, Y., & Shin, J. H. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00694 · Cited by 10
Thennavan, A., García‐Recio, S., Liu, S., He, X., & Perou, C. M. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00450-w · Cited by 9
TGF-β controls stromal telomere length through epigenetic modifications
Mishra, R., Haldar, S., Biondi, S., Bhari, V. K., Singh, G., & Bhowmick, N. A. (2022) · 3 Biotech · doi:10.1007/s13205-022-03346-5 · Cited by 9
The role of cancer‐associated fibroblasts in the tumour microenvironment of urinary system
Hong, R., Yu, P., Zhang, X., Su, P. C., Liang, H., Dong, D. F., Wang, X., & Wang, K. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70299 · Cited by 8
Identification of a Notch transcriptomic signature for breast cancer
Braune, E.-B., Geist, F., Tang, X., Kalari, K. R., Boughey, J. C., Wang, L., Leon-Ferre, R. A., D’Assoro, A. B., Ingle, J. N., Goetz, M. P., et al. (2024) · Breast Cancer Research · doi:10.1186/s13058-023-01757-7 · Cited by 8
Self-citationJagged1 regulates extracellular matrix deposition and remodeling in triple-negative breast cancer
Parikainen, M., Suwal, U., Rappu, P., Heino, J., & Sahlgren, C. (2026) · Science Advances · doi:10.1126/sciadv.aea9562 · Cited by 11
Metadata
- Authors
- Strell, C., Paulsson, J., Jin, S.-B., Tobin, N. P., Mezheyeuski, A., Roswall, P., Mutgan, C., Mitsios, N., Johansson, H., Wickberg, S. M., Svedlund, J., Nilsson, M., Hall, P., Mulder, J., Radisky, D. C., Pietras, K., Bergh, J., Lendahl, U., Wärnberg, F., & Östman, A.
- Affiliations
- Stockholm University (SE)
- Karolinska Institutet (SE)
- Lund University (SE)
- Uppsala University (SE)
- Mayo Clinic in Florida (US)
- Corresponding author
- Strell, Carina
- ORCID
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-02-28
- Volume
- 111
- Issue
- 9
- Pages
- 983-995
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- PMC
- PMC6748730
- OpenAlex
- W2920295895
- Cited by
- 158
- References
- 59
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 25 · 2023: 19 · 2022: 36 · 2021: 30 · 2020: 19 · 2019: 4
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Swedish Cancer Society (150895)
- Swedish Research Council (349–2006-160)
- Radiumhemmets forskningsfonder, EU Caffein ITN network (3047/12)
- BRECT network of Karolinska Institutet
- Stockholm County Council
- Comprehensive Cancer Consortium
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- ductal carcinoma in situ, stromal-epithelial interactions, PDGFR, PDGFRA, PDGFRβ, fibroblast phenotype, local recurrence, JAG1, Notch2, juxtacrine signaling, prognostic factors, breast cancer
- MeSH terms
- Cancer-Associated Fibroblasts, Adult, Aged, Aged, 80 and over, Animals, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Cell Communication, Disease Models, Animal, Epithelial Cells, Female, Humans, Immunohistochemistry, Middle Aged, Prognosis, Biomarkers, Tumor, Stromal Cells, Receptors, Platelet-Derived Growth Factor, Coculture Techniques, Computational Biology, Gene Expression Profiling, Cell Line, Tumor, Mice, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
